GLP-1 weight-loss drugs like Ozempic are reshaping how consumers eat, prompting food and beverage manufacturers to develop precision nutrition solutions using AI and functional ingredients to personalize diets and target metabolism more effectively.
The weight-loss revolution sparked by GLP-1 drugs like Ozempic and Mounjaro is transforming the food industry's relationship with biology, as millions of consumers re-evaluate their eating habits.
Precision nutrition is about aligning what we eat with who we are - biologically, metabolically, and behaviourally.
As millions of consumers re-evaluate what, when and how they eat, a parallel movement is gaining momentum: precision nutrition.
Author's summary: GLP-1 drugs drive precision nutrition.